Market Overview:
The global Oligonucleotide Therapy market, valued at USD 4,207.20 million in 2021, is projected to grow at a compound annual growth rate (CAGR) of 15.80% from 2024 to 2031. Oligonucleotide therapies involve short-chain RNA or DNA designed to inhibit gene expression and treat various genetic and neurodegenerative conditions.
Market Trends:
Technological advancements in antisense...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian